Icelandirect Acquires SOMA LABS to Expand Human and Pet Supplement Dosage Form Manufacturing Capabilities
March 20, 2026
Icelandirect, a U.S.-based contract manufacturer and portfolio company of New Heritage Capital, acquired SOMA LABS, a New Jersey supplement manufacturer specializing in solid dosage form production. The transaction closed in February 2026 and expands Icelandirect’s capabilities to include powders, capsules, tablets, and chewables for both human nutrition and pet supplement brands.
- Buyers
- Icelandirect
- Targets
- SOMA LABS
- Industry
- Manufacturing
- Location
- New Jersey, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.